Subscribe

JMDC Inc. (4483.T)

JPY3,220.00 -5.00 (-0.16%)
JP JPX Healthcare Medical - Healthcare Information Services
Address Sumitomo Shiba Daimon Building 105-0012
Tokyo, JP
CEO Ryo Noguchi
Website jmdc.co.jp
IPO 2019-12-16
ISIN JP3386690006

Explore sections of this company profile

Description

JMDC Inc. is a Japanese corporation primarily focused on delivering analytical and statistical services for the medical sector. Its operations are structured across three principal divisions: Healthcare-Big Data, Telemedicine, and Dispensing Pharmacy Support. Within the Healthcare-Big Data segment, the company provides extensive big data solutions tailored for both the medical and life insurance industries. It also offers crucial support services to health insurance associations and local government health programs, develops a robust health data platform, and aids medical institutions. The Telemedicine division facilitates remote medical imaging interpretation through specialized matching services and ASP systems. Concurrently, its Dispensing Pharmacy Support segment develops and markets bespoke business management software specifically designed for dispensing pharmacies. JMDC serves a broad spectrum of clients, including health insurance providers, pharmaceutical manufacturers, life and general insurance companies, and research organizations. The company, established in 2002, maintains its corporate headquarters in Tokyo, Japan.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
JPY3,220.00 -5.00 (-0.16%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
530.3K
Beta
0.80
Float Shares
25.51M
Free Float %
39.0%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-7.92% -27.18% -30.48% -33.50% -44.16% -37.16% -26.59% -56.95% -48.66% +30.71% +30.71%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
3,220.00
DCF (Unlevered) 3,555.60 +10.4%
DCF (Levered) 4,009.67 +24.5%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 3 0
Buy 8 -1
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
2.44
Grey zone
Piotroski F-Score
5 / 9
Average
MOAT Score
7 / 10
Strong MOAT
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Healthcare Information Services: +14.2%
    +21.0% ★ Q1'26: +25.7% (vs Q1'25)
  • ✓
    EPS growth Medical - Healthcare Information Services: +43.1%
    +13.5% Q1'26: -6.9% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%
    +17.6% Q1'26: +20.2% (vs Q1'25)
  • ✗
    EBIT margin Medical - Healthcare Information Services: +8.8%
    +19.8% ★ Q1'26: +18.8% (vs Q1'25)
  • ✗
    ROIC Medical - Healthcare Information Services: +5.2%
    +6.4% ★ Q1'26: +7.4% (vs Q1'25)
  • ✗
    Share dilution Medical - Healthcare Information Services: -0.1%
    +0.0% ★ Q1'26: 0.0% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×
    3.95× Q1'26: 3.72× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.54) × ERP
WACC = 81% × Ke + 19% × Kd (4.0%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 3,555.60 Current price: 3,220.00
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Mar 2020
actual 		Mar 2021
actual 		Mar 2022
actual 		Mar 2023
actual 		Mar 2024
actual 		Mar 2025
actual 		Mar 2026
14 Rev. Ana.
14 EPS Ana. 		Mar 2027
8 Rev. Ana.
14 EPS Ana. 		Mar 2028
13 Rev. Ana.
13 EPS Ana. 		Mar 2029
4 Rev. Ana.
4 EPS Ana. 		Mar 2030
3 Rev. Ana.
2 EPS Ana. 		Mar 2031
2 Rev. Ana.
3 EPS Ana.
Revenue
12.16B
est: 11.79B (+3.1%)
16.77B
est: 16.23B (+3.4%)
21.81B
est: 22.14B (-1.5%)
27.81B
est: 27.73B (+0.3%)
30.57B
est: 34.11B (-10.4%)
41.72B
est: 43.25B (-3.5%)
50.75B
49.97B – 51.38B
+17.3% YoY
60.63B
60.13B – 61.32B
+19.5% YoY
71.38B
64.18B – 76.74B
+17.7% YoY
82.13B
82.04B – 82.21B
+15.1% YoY
94.34B
88.82B – 98.67B
+14.9% YoY
119.10B
112.13B – 124.57B
+26.2% YoY
EBITDA
3.25B
est: 3.39B (-4.1%)
4.89B
est: 4.67B (+4.8%)
6.45B
est: 6.37B (+1.3%)
7.73B
est: 7.97B (-3.0%)
8.80B
est: 9.44B (-6.9%)
10.93B
est: 11.98B (-8.7%)
14.05B
13.83B – 14.23B
+17.3% YoY
16.79B
16.65B – 16.98B
+19.5% YoY
19.76B
17.77B – 21.25B
+17.7% YoY
22.74B
22.72B – 22.76B
+15.1% YoY
26.12B
24.59B – 27.32B
+14.9% YoY
32.98B
31.05B – 34.49B
+26.2% YoY
EBIT
2.36B
est: 2.55B (-7.5%)
3.72B
est: 3.51B (+6.0%)
4.76B
est: 4.79B (-0.7%)
5.72B
est: 6.00B (-4.8%)
6.70B
est: 7.08B (-5.4%)
8.22B
est: 8.97B (-8.4%)
10.53B
10.37B – 10.66B
+17.3% YoY
12.58B
12.48B – 12.72B
+19.5% YoY
14.81B
13.32B – 15.93B
+17.7% YoY
17.04B
17.02B – 17.06B
+15.1% YoY
19.58B
18.43B – 20.48B
+14.9% YoY
24.71B
23.27B – 25.85B
+26.2% YoY
Net Income
1.53B
est: 1.79B (-14.6%)
2.48B
est: 2.92B (-15.2%)
3.25B
est: 4.08B (-20.5%)
4.27B
est: 4.30B (-0.8%)
3.32B
est: 3.29B (+0.8%)
5.96B
est: 6.09B (-2.2%)
7.43B
6.97B – 7.88B
+21.9% YoY
9.13B
7.52B – 10.51B
+22.9% YoY
11.39B
8.95B – 14.18B
+24.8% YoY
13.53B
12.19B – 16.49B
+18.8% YoY
16.98B
15.69B – 18.00B
+25.5% YoY
—
— – —
-100.0% YoY
SGA
3.76B
est: 3.88B (-3.1%)
5.21B
est: 5.33B (-2.3%)
6.67B
est: 7.28B (-8.3%)
8.90B
est: 9.11B (-2.4%)
10.22B
est: 11.25B (-9.1%)
14.10B
est: 14.26B (-1.1%)
16.74B
16.48B – 16.94B
+17.3% YoY
20.00B
19.83B – 20.22B
+19.5% YoY
23.54B
21.17B – 25.31B
+17.7% YoY
27.08B
27.06B – 27.11B
+15.1% YoY
31.11B
29.29B – 32.54B
+14.9% YoY
39.28B
36.98B – 41.08B
+26.2% YoY
EPS
31.45
est: 27.12 (+16.0%)
46.54
est: 44.22 (+5.2%)
57.73
est: 61.88 (-6.7%)
71.16
est: 65.19 (+9.2%)
51.72
est: 50.83 (+1.7%)
91.22
est: 98.83 (-7.7%)
112.34
105.59 – 119.34
+13.7% YoY
142.32
113.86 – 159.23
+26.7% YoY
176.99
135.49 – 214.78
+24.4% YoY
217.29
184.58 – 249.76
+22.8% YoY
257.23
237.67 – 272.60
+18.4% YoY
—
— – —
-100.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-08 B 3/5 5/5 3/5 4/5 1/5 2/5 2/5
2026-05-07 B 3/5 5/5 3/5 4/5 1/5 2/5 2/5
2026-05-01 B 3/5 5/5 3/5 4/5 1/5 2/5 2/5
2026-04-30 B 3/5 5/5 3/5 4/5 1/5 2/5 2/5
2026-04-28 B 3/5 5/5 3/5 4/5 1/5 2/5 2/5
2026-04-27 B 3/5 5/5 3/5 4/5 1/5 2/5 2/5
2026-04-24 B+ 3/5 5/5 3/5 5/5 1/5 2/5 2/5
2026-04-23 B+ 3/5 5/5 3/5 5/5 1/5 2/5 2/5
2026-04-22 B+ 3/5 5/5 3/5 5/5 1/5 2/5 2/5
2026-04-21 B+ 3/5 5/5 3/5 5/5 1/5 2/5 2/5
2026-04-20 B+ 3/5 5/5 3/5 5/5 1/5 2/5 2/5
2026-04-17 B+ 3/5 5/5 3/5 5/5 1/5 2/5 2/5
2026-04-16 B+ 3/5 5/5 3/5 5/5 1/5 2/5 2/5
2026-04-15 B+ 3/5 5/5 3/5 5/5 1/5 2/5 2/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
11.88B
OE per share TTM
180.10
Owner's Yield
5.40%
Maintenance CapEx ratio
49.27%
Maint CapEx / Avg PPE
39.8%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
5.63M
Shares Outstanding
65.42M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Akihiro Kosako Executive Officer — male
Akio Yonekura Executive Officer — male
Hamada Takayuki Executive Officer — —
Hirokazu Iwai Executive Officer — male
Hiroshi Kuraoka Executive Officer & Chief Product Officer — male
Masatoshi Adachi Executive Officer & Chief Data Protection Officer — —
Ryo Noguchi President, Chief Executive Officer & Representative Director — male
Yasunobu Sakai Executive Officer — —
Yoichi Mihara Executive Officer — —
Yuzuru Kubota Chief Financial Officer & Executive Officer — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Healthcare Information Services